Alzheimer’s disease and related dementias affect a staggering number of families, and can devastate the lives of all involved.
The Alzheimer’s Association estimates that one in three seniors in the United States dies with a diagnosis of Alzheimer’s or dementia. 16 million more individuals serve as unpaid caregivers, providing hundreds of billions of dollars of uncompensated care to their loved ones. This caregiving can lead to much higher levels of stress and worse health outcomes for caregivers.
From using passive markers to identify the disease, to the impact of dementia screening and medications to how best to care for patients and their families, Regenstrief Institute is conducting a significant amount of research on dementia.
Researchers are working to understand the relationship between dementia and anticholinergics, as well as how to safely deprescribe medicines. They are also focused on treating and preventing delirium in the intensive care unit, which greatly increases a person’s odds of developing dementia.
A collaborative care model utilizing a team of healthcare workers to treat not only the patient with dementia but the family as well was developed at Regenstrief. Care models such as this along with other interventions to support caregivers are an important cornerstone of dementia research.
Related News & Stories
Factors influencing participation of Black and White Americans in Alzheimer’s disease biomarker research
Regenstrief researcher leads study of barriers to participation and drivers of engagement The use of Alzheimer’s disease (AD) biomarkers such as amyloid and tau levels to...
Dementia complicates cancer care, increasing risk of poorer clinical outcomes and patient experience
Review authors make recommendations for treatment of cancer in patients with dementia Pre-existing dementia complicates cancer care and increases the risk of worse clinical outcomes and...
$11M NIH grant will support evaluation of Alzheimer’s screening tool in primary care settings
Researchers Led by Albert Einstein College of Medicine, Montefiore Health System, Regenstrief Institute, and IU School of Medicine Will Evaluate Test in Urban and Rural Communities...
Redesigning diabetes technology to detect low blood sugar in older adults with diabetes and Alzheimer’s disease
Regenstrief Institute Research Scientist April Savoy, PhD, a human factors engineer and health services researcher, is developing and testing user-friendly health information tools and technology designed...
Regenstrief research scientist 1 of 33 NIA small business mentors
Regenstrief Research Scientist Malaz Boustani, M.D., MPH, was one of 33 mentors for the National Institutes of Health’s National Institute on Aging (NIA) 2022 Healthy Aging...